EMD-24301
SARS-CoV-2 spike glycoprotein ectodomain in complex with the S2H97 neutralizing antibody Fab fragment
EMD-24301
Single-particle3.64 Å
Deposition: 25/06/2021Map released: 21/07/2021
Last modified: 15/09/2021
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: SARS-CoV-2 spike glycoprotein ectodomain in complex with the S2H97 neutralizing antibody Fab fragment
Deposition Authors: Park YJ, Veesler D
Sample: SARS-CoV-2 spike glycoprotein ectodomain in complex with the S2H97 neutralizing antibody Fab fragment
Deposition Authors: Park YJ, Veesler D
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
Starr TN 
,
Czudnochowski N,
Liu Z ,
Zatta F,
Park YJ ,
Addetia A,
Pinto D,
Beltramello M,
Hernandez P ,
Greaney AJ,
Marzi R ,
Glass WG,
Zhang I ,
Dingens AS ,
Bowen JE ,
Tortorici MA ,
Walls AC ,
Wojcechowskyj JA,
De Marco A,
Rosen LE ,
Zhou J ,
Montiel-Ruiz M ,
Kaiser H ,
Dillen JR,
Tucker H,
Bassi J,
Silacci-Fregni C,
Housley MP,
di Iulio J,
Lombardo G,
Agostini M,
Sprugasci N,
Culap K ,
Jaconi S ,
Meury M,
Dellota Jr E,
Abdelnabi R ,
Foo SC ,
Cameroni E,
Stumpf S,
Croll TI ,
Nix JC ,
Havenar-Daughton C ,
Piccoli L ,
Benigni F,
Neyts J ,
Telenti A ,
Lempp FA ,
Pizzuto MS ,
Chodera JD ,
Hebner CM,
Virgin HW ,
Whelan SPJ,
Veesler D ,
Corti D ,
Bloom JD ,
Snell G
(2021) Nature , 597 , 97 - 102
,
Czudnochowski N,
Liu Z ,
Zatta F,
Park YJ ,
Addetia A,
Pinto D,
Beltramello M,
Hernandez P ,
Greaney AJ,
Marzi R ,
Glass WG,
Zhang I ,
Dingens AS ,
Bowen JE ,
Tortorici MA ,
Walls AC ,
Wojcechowskyj JA,
De Marco A,
Rosen LE ,
Zhou J ,
Montiel-Ruiz M ,
Kaiser H ,
Dillen JR,
Tucker H,
Bassi J,
Silacci-Fregni C,
Housley MP,
di Iulio J,
Lombardo G,
Agostini M,
Sprugasci N,
Culap K ,
Jaconi S ,
Meury M,
Dellota Jr E,
Abdelnabi R ,
Foo SC ,
Cameroni E,
Stumpf S,
Croll TI ,
Nix JC ,
Havenar-Daughton C ,
Piccoli L ,
Benigni F,
Neyts J ,
Telenti A ,
Lempp FA ,
Pizzuto MS ,
Chodera JD ,
Hebner CM,
Virgin HW ,
Whelan SPJ,
Veesler D ,
Corti D ,
Bloom JD ,
Snell G
(2021) Nature , 597 , 97 - 102
Grant Support: